United Therapeutics buy UBS Group AG
Start price
04.09.25
/
50%
€337.60
Target price
04.09.26
€480.20
Performance (%)
-0.44%
Price
15:41
€336.10
Summary
This prediction is currently active. Since the start of the prediction for United Therapeutics the price has only changed by -0.44%. This prediction currently runs until 04.09.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| United Therapeutics | -0.44% |
| iShares Core DAX® | -1.150% |
| iShares Nasdaq 100 | 0.889% |
| iShares Nikkei 225® | 1.183% |
| iShares S&P 500 | 0.159% |
Comments by UBS_Group_AG for this prediction
In the thread United Therapeutics diskutieren
United Therapeutics (NASDAQ:UTHR) had its price target raised by analysts at UBS Group AG from $415.00 to $560.00. They now have a "buy" rating on the stock.
Ratings data for UTHR provided by MarketBeat
Stopped prediction by UBS_Group_AG for United Therapeutics
United Therapeutics
Start price
Target price
Perf. (%)
€258.80
13.08.25
13.08.25
€355.41
13.08.26
13.08.26
29.87%
15:41
15:41
United Therapeutics
Start price
Target price
Perf. (%)
€244.10
30.06.25
30.06.25
€328.48
30.06.26
30.06.26
37.69%
15:41
15:41
United Therapeutics
Start price
Target price
Perf. (%)
€355.30
08.01.25
08.01.25
€460.94
08.01.26
08.01.26
-5.40%
15:41
15:41
United Therapeutics
Start price
Target price
Perf. (%)
€292.80
08.07.24
08.07.24
€341.51
08.07.25
08.07.25
-14.82%
09.07.25
09.07.25